Markus Fally

Clinical Associate Professor @uni_copenhagen
MD, PhD, MPH @SUHhospital
Guidelines methodologist @EuroRespSoc
Editor @Ugeskriftet

[Markus Fally @MarkusFally]

@VirtueOfNothing @timwfelton @MathioudakisAG @CMIJournal

[Markus Fally @MarkusFally]

https://t.co/OgKyLCqSIq

[Markus Fally @MarkusFally]

@VirtueOfNothing @timwfelton @MathioudakisAG

[Markus Fally @MarkusFally]

🚨 Thrilled to share our latest comprehensive systematic review on diagnostic criteria for community-acquired #pneumonia in clinical trials 🤒
Only 69.4% of CAP studies registered between 2010 and 2024 provided diagnostic criteria, using 87 different combinations 😵‍💫

[Markus Fally @MarkusFally]

@IDSAInfo

[Markus Fally @MarkusFally]

🚨 Excited to share our latest research on lower respiratory tract samples and their role in community-acquired #pneumonia 🤒

🔍 Insights from our study: LRTS collection led to increased antibiotic use, longer hospital stays, and lower 90-day mortality

https://t.co/Vu9iHfbpvl

[MathioudakisAG @MathioudakisAG]

European Respiratory Society guidelines for the Diagnosis and Management of Pulmonary Alveolar Proteinosis.
https://t.co/RiCt03rRuc
@ERSpublications
@ManchesterBRC

[Critical Care @Crit_Care]

#CritCare #OpenAccess

Unravelling the complexity of ventilator-associated pneumonia: a systematic methodological literature review of diagnostic criteria and definitions used in clinical research

Read the full article: https://t.co/Usc3Q1BlNQ

@jlvincen @ISICEM #FOAMed #FOAMcc

[MathioudakisAG @MathioudakisAG]

🚨Unravelling the complexity of ventilator-associated pneumonia #VAP: a systematic review of diagnostic criteria and definitions.
https://t.co/Znc7KU3Ufq
Read our new study @Crit_Care led by @MarkusFally.
@VirtueOfNothing, @timwfelton, @ManchesterBRC

[MathioudakisAG @MathioudakisAG]

#Pneumonia #RCTs use a wide variety of outcomes and outcome measurement instruments. Most frequently reported: treatment success (61%), mortality (56%) and AE (41%). There is a need for a rigorous core outcome set #COS - in development by the @EuroRespSoc
https://t.co/VUdpN9kwic

[Markus Fally @MarkusFally]

Still possible to help the respiratory community by completing the survey below - deadline 20 August 🙏

[Markus Fally @MarkusFally]

Do you have experience with #Pneumonia as a patient, a relative to a patient or a healthcare professional? 🤒
Help the @EuroRespSoc develop #CoreOutcomeSets for future #Pneumonia trials: https://t.co/145XSKmCA1
And please share 🙏

[ERS @EuroRespSoc]

ERS invites its members and the wider respiratory health community to take part in a survey which will help develop core outcome sets for the management of pneumonia.

Take they survey by 20 July, 2023: https://t.co/0jXN68rYm8

[Markus Fally @MarkusFally]

For those who have problems with the short link, here's the original one: https://t.co/tCR76S333d

[Markus Fally @MarkusFally]

Do you have experience with #Pneumonia as a patient, a relative to a patient or a healthcare professional? 🤒
Help the @EuroRespSoc develop #CoreOutcomeSets for future #Pneumonia trials: https://t.co/145XSKmCA1
And please share 🙏

[MathioudakisAG @MathioudakisAG]

Core Outcome Sets can Improve Quality and Comparability of Clinical Trials in Respiratory Medicine.
@EuroRespSoc has endorsed 3 #COS
Read our Editorial @ERSpublications
https://t.co/D2HQjbeCoL

@ProfJVestbo @KateKhaleva @DoctorJensUlrik @timwfelton @EuropeanLung @ManchesterBRC